Pharmaceutical company Celgene Corporation is collaborating with Versant Ventures' biotech incubator Blueline Bioscience to develop biotech startups in Toronto, Canada.
Blueline Bioscience, a Canada-based biotech incubator launched by venture capital firm Versant Ventures in September 2013, has entered into a collaboration with US-based pharmaceutical company Celgene Corporation.
Upon launch of new enterprises by Blueline Bioscience in areas of joint strategic interest such as oncology and inflammation, an affiliate of Celgene Corporation will have certain option rights through the collaboration.
Stefan Larson, president of Blueline Bioscience and an entrepreneur-in-residence with Versant Ventures, said: “With the collaboration and option agreement now…
